WebJan 10, 2024 · The Scandinavian Neurotrauma Committee (SNC) has recommended the use of serum S100B as a biomarker for mild low-risk Traumatic brain injuries (TBI). This study aimed to assess the adherence to the SNC guidelines in clinical practice and the diagnostic performance of S100B in patients with TBI. WebApr 30, 2024 · Similarly, S100B protein level can predict the occurrence of the post-concussion syndrome after mild TBI [10, 36]. There is also a positive association between S100 protein levels and intracranial pressure and cranial CT after TBI . S100B protein levels can predict normal CT after mTBI, reducing unnecessary CT scans.
Utility of neuron-specific enolase in traumatic brain injury; …
WebApr 13, 2024 · Traumatic brain injury (TBI) has been implicated as a risk factor for developing various neurodegenerative diseases, with the most compelling argument for the development of PD. ... Piperi, C. Emerging role of S100B protein implication in Parkinson’s disease pathogenesis. Cell. Mol. Life Sci. 2024, 78, 1445–1453. [Google Scholar] Chu, H.-Y … WebS100B is a useful neurobiochemical marker of brain damage such as in circulatory arrest, stroke and traumatic brain injury. S100B is also associated with neurodegenerative … restech south africa
Frontiers Is Salivary S100B a Biomarker of Traumatic …
WebOct 29, 2024 · Lippi, G. & Cervellin, G. Protein S100B: from cancer diagnostics to the evaluation of mild traumatic brain injury. Clin Chem Lab Med 54 , 703–705 (2016). PubMed CAS Google Scholar WebMar 21, 2024 · Following brain injury, S100B can also be passively released by dying damaged astrocytes into the circulation via the BBB, with rapid clearance thereafter (half-life 60–120 min). This may be the main trigger of secondary, delayed increases in S100B (or GFAP) after TBI (38, 39). These are usually correlated with secondary adverse events. WebApr 1, 2024 · S100B protein has emerged as the most widely studied and used biomarker for clinical decision making in patients with mTBI. In addition to its use as a diagnostic biomarker, S100B plays an active role in the molecular pathogenic processes accompanying acute brain injury. restech rope